SHIP limits immunoregulatory capacity in the T-cell compartment.
about
A small-molecule inhibitor of SHIP1 reverses age- and diet-associated obesity and metabolic syndromeT-cell immunoglobulin and ITIM domain (TIGIT) receptor/poliovirus receptor (PVR) ligand engagement suppresses interferon-γ production of natural killer cells via β-arrestin 2-mediated negative signalingSHIP1 inhibition increases immunoregulatory capacity and triggers apoptosis of hematopoietic cancer cells.Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and functionDiscovery and development of small molecule SHIP phosphatase modulators.SHIPi Enhances Autologous and Allogeneic Hematolymphoid Stem Cell Transplantation.Preparation of myeloid derived suppressor cells (MDSC) from naive and pancreatic tumor-bearing mice using flow cytometry and automated magnetic activated cell sorting (AutoMACS).Imbalanced signal transduction in regulatory T cells expressing the transcription factor FoxP3.Mouse natural killer cell development and maturation are differentially regulated by SHIP-1.Regulatory myeloid suppressor cells in health and diseaseAnti-CD3 antibodies modulate anti-factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapy.Inhibitor and activator: dual functions for SHIP in immunity and cancer.Role of inositol poly-phosphatases and their targets in T cell biology.Signals and pathways controlling regulatory T cells.Regulation of immune cell signaling by SHIP1: A phosphatase, scaffold protein, and potential therapeutic target.Lineage extrinsic and intrinsic control of immunoregulatory cell numbers by SHIP.Role of SHIP1 in Invariant NKT Cell Development and Functions.SHIP1 intrinsically regulates NK cell signaling and education, resulting in tolerance of an MHC class I-mismatched bone marrow graft in miceImpaired T-cell survival promotes mucosal inflammatory disease in SHIP1-deficient mice.Does the PI3K pathway promote or antagonize regulatory T cell development and function?SHIP deficiency causes Crohn's disease-like ileitis.Pharmacological targeting of phosphoinositide lipid kinases and phosphatases in the immune system: success, disappointment, and new opportunities.SHIP-1 inhibits CD95/APO-1/Fas-induced apoptosis in primary T lymphocytes and T leukemic cells by promoting CD95 glycosylation independently of its phosphatase activity.Expression of microRNA-155 in inflammatory cells modulates liver injury.KMT1E-mediated chromatin modifications at the FcγRIIb promoter regulate thymocyte development.SHIP1 Deficiency in Inflammatory Bowel Disease Is Associated With Severe Crohn's Disease and Peripheral T Cell Reduction.Myeloid cell-specific expression of Ship1 regulates IL-12 production and immunity to helminth infection
P2860
Q28830272-231722B2-D849-49AF-9ABD-F53D54A6617FQ33792958-A8FBCCFF-9852-4C6A-96D9-93C8F2A060D7Q34008167-E4DED0B0-36BD-48E9-B65D-E4538679FA46Q34087816-36B21748-E088-4086-ACEB-294C22057274Q35058356-6B8C0886-6D34-4983-9807-3B436EF06408Q35673839-44FBF65B-4365-4158-8B56-C9ECFCF218BCQ36317387-224F9E50-CBF3-4E10-AF82-1EAFE47560AFQ36354925-E97A7E9B-80ED-4690-80D3-3963EA199871Q36440073-0C84DEB7-F038-40D5-B964-91660BF4A5E1Q37373257-2200AD3F-2C20-43C9-9EB5-993E7E98EAECQ37420500-C6F5EBB4-877F-4F26-BFC3-4ABAB3038524Q37820689-035C9F83-BE7A-4875-B090-0BCFB2570A90Q38143834-2E377927-E526-4FCA-90F7-B1612DCD30E9Q38187171-C03D76B5-5296-438D-8DB9-E85AD308A97FQ38799014-8C577AA9-CC05-4A75-88DD-CE7799DBCF98Q39358461-CE41F55C-3A1D-4476-9010-80243A20E4BCQ40671337-0ED3F74A-E937-4D0A-9DA5-D62424919AF6Q41479963-15C50F55-7510-4B6E-9F81-06997423EF42Q41842794-905618BC-6545-464A-B8C9-6BCF12C3D8E6Q41864874-7459C7CF-9222-40F7-9040-428B9FEB05E1Q42072927-A12BDA99-AAF2-4F68-9EB9-237BBDC85636Q42178173-0BF7F1FB-E062-4C03-90F5-C3B82BF5DAF7Q43165889-83782A4C-2AEE-40A1-BD47-1D114B27E965Q48506045-E45EA790-1F62-4B59-A6EA-746BABECE8CDQ53225237-5FC83432-67E0-4865-8077-30B14AD5D117Q54977493-D0FFD6BB-787E-4C8A-925C-093BEC6B7BD4Q59280514-9DA711E0-B876-4BC4-AA3B-8B5A307D0A04
P2860
SHIP limits immunoregulatory capacity in the T-cell compartment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
SHIP limits immunoregulatory capacity in the T-cell compartment.
@en
SHIP limits immunoregulatory capacity in the T-cell compartment.
@nl
type
label
SHIP limits immunoregulatory capacity in the T-cell compartment.
@en
SHIP limits immunoregulatory capacity in the T-cell compartment.
@nl
prefLabel
SHIP limits immunoregulatory capacity in the T-cell compartment.
@en
SHIP limits immunoregulatory capacity in the T-cell compartment.
@nl
P2093
P2860
P1433
P1476
SHIP limits immunoregulatory capacity in the T-cell compartment
@en
P2093
Cam-Tien Le
Daniela Wood
Diana Stauch
Katja Kotsch
Kim H T Paraiso
Michelle M Collazo
Robert W Engelman
P2860
P304
P356
10.1182/BLOOD-2008-09-181164
P407
P577
2009-01-09T00:00:00Z